 |
 |
|
|
RESÚMENES ABRIL 2008 |
Schizophrenia-Psychotic Disorders & Antipsychotics
(Haga un click en la información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 –
revisión, abierto, básico; 2 – casos; 1 – opinión
GRATIS = Texto gratuito en algunos
países de la región iberoamericana (algunos artículos requieren ir a la tabla
de contenidos del número actual de la revista)
GRATIS 3 - Do Dopamine Partial Agonists
Have Partial Efficacy as Antipsychotics?
Stephen
M. Stahl
CNS Spectr. 2008;13(4):279-282
GRATIS 3 - Metabolic Adverse
Events in Patients With Mental Illness Treated With
Antipsychotics: A Primary Care Perspective
Gabriela Balf,
Thomas D. Stewart, Richard Whitehead, and Ross A. Baker
Prim Care Companion J Clin
Psychiatry. 2008; 10(1): 15–24
GRATIS 3< - Mortality Risks and Antipsychotics
Donald S.
Robinson
Primary
Psychiatry. 2008;15(4):21-23
GRATIS 3 - Negative Symptoms
in Schizophrenia: The Importance of Identification and Treatment
Dawn I. Velligan
and Larry D. Alphs
Psychiatric Times 2008;Vol.
25 No. 3
GRATIS 3 - Nicotine
Dependence in Schizophrenia: Prevalence, Mechanisms, and Implications for
Treatment
A. Eden Evins
Psychiatric Times 2008; Vol. 25 No. 3
GRATIS 3 - Síndrome neuroléptico
maligno
VARGAS, Adriana y GOMEZ-RESTREPO, Carlos
rev.colomb.psiquiatr., oct. 2007, vol.36 supl.1, p.101-125
3 - Clinical and Pharmacoeconomic Evaluation of
Switch to Olanzapine in Veterans with Schizophrenia
or Schizoaffective Disorder
Lori L. Davis, Marshall E. Cates, Joette S. Lowe, L. Charles Ward, Jeffrey D. Johnson, Raela B.Williford, Sandra M.
Ambrose, Brandi L. Thomas, and
Terrell
Michael Kashner
Psychopharmacology Bulletin. 2008; 41( 1): 85- 98
3 - The Revised Dopamine Hypothesis of Schizophrenia: Evidence from
Pharmacological MRI Studies with Atypical Antipsychotic Medication
Fabiana da Silva Alves, Martijn Figee, Therese van Amelsvoort,
Dick Veltman, and Lieuwe de
Haan
Psychopharmacology Bulletin. 2008; 41( 1): 121- 132
5 - Longitudinal studies of cognition in schizophrenia:
meta-analysis
Andrei Szöke, Anca Trandafir, Marie-Estelle Dupont, Alexandre Méary, Franck Schürhoff, and Marion Leboyer
The
British Journal of Psychiatry (2008) 192: 248-257
3 -
Congenital anomalies
and early functional impairments in a prospective birth cohort: risk of
schizophrenia-spectrum disorder in adulthood
John L. Waddington, Alan S.
Brown, Abbie Lane, Catherine A. Schaefer, Raymond R.
Goetz, Michaeline Bresnahan,
and Ezra S. Susser
The British Journal of Psychiatry (2008) 192:
264-267
3! - Effects of cannabidiol on
schizophrenia-like symptoms in people who use cannabis
Celia J. A. Morgan, H. Valerie Curran
The
British Journal of Psychiatry (2008) 192: 306-307
3! -
Excessive Brain
Volume Loss Over Time in Cannabis-Using First-Episode
Schizophrenia Patients
Monica Rais, Wiepke
Cahn, Neeltje Van Haren,
Hugo Schnack, Esther Caspers,
Hilleke Hulshoff Pol, and René Kahn
Am J
Psychiatry 2008; 165:490-496
3 - Agonist and antagonist
properties of antipsychotics at human dopamine D4.4 receptors:
G-protein activation and K+ channel modulation in transfected cells
Adrian Newman-Tancredi, Peter Heusler, Jean-Claude
Martel, Anne-Marie Ormière, Nathalie Leduc and Didier
Cussac
The
International Journal of Neuropsychopharmacology
(2008), 11:293-307
3 - ST2472: a new potential
antipsychotic with very low liability to induce side-effects
Maria A. Stasi, Stefano Di Serio,
Mario Vertechy, Antonio Schiavone, Orlando Ghirardi, Patrizia Minetti, Giuseppe
Campiani, Franco Borsini and Paolo Carminati
The
International Journal of Neuropsychopharmacology
(2008), 11:309-319
3 - Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [18F]Fallypride PET Study
Gerhard Gründer, Christine Fellows, Hildegard Janouschek, Tanja Veselinovic, Christian Boy, Anno Bröcheler,
Katrin M. Kirschbaum,
Sandra Hellmann, Katja M. Spreckelmeyer,
Christoph Hiemke, Frank Rösch, Wolfgang M. Schaefer, and Ingo Vernaleken
Am J Psychiatry Published April 1, 2008
5 -
Initial Phase 2
Trial of a Nicotinic Agonist in Schizophrenia
Robert Freedman, Ann Olincy, Robert W.
Buchanan, Josette G. Harris, James M. Gold, Lynn
Johnson, Diana Allensworth, Alejandrina
Guzman-Bonilla, Bettye Clement, M.Patricia Ball, Jay Kutnick, Vicki Pender, Laura F. Martin, Karen E. Stevens,
Brandie D. Wagner, ary O. Zerbe,
Ferenc Soti, and William R.
Kem
Am J Psychiatry Published
April 1, 2008
3 - Sexual dysfunction in
schizophrenia: focus on recent evidence
Martin Baggaley
Human
Psychopharmacology: Clinical and Experimental. Volume 23, Issue 3, Pages 201 - 209
3! - Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight
patients with chronic schizophrenia. A 1 year open-label, prospective trial
Bharat Chawla,
Heather Luxton-Andrew
Human
Psychopharmacology: Clinical and Experimental. Volume 23, Issue 3, Pages 211 - 216
3 - Does
traumatic brain injury predispose individuals to develop schizophrenia?
Kim, Edward
Current Opinion in Psychiatry. 21(3):286-289, May 2008
GRATIS 4 - Cost of Antipsychotic Polypharmacy
in the Treatment of Schizophrenia
Baojin Zhu, Haya Ascher-Svanum, Douglas E Faries, Christoph U Correll
and John M Kane
3! - Cancer incidence in patients with schizophrenia and
their first-degree relatives - a meta-analysis
V. S. Catts, S. V. Catts,
B. I. O’Toole, A. D. J. Frost
Acta Psychiatrica Scandinavica 2008;
117 (5), 323–336
5 - Diabetes and schizophrenia - effect of disease or drug?
Results from a randomized, double-blind, controlled prospective study in
first-episode schizophrenia
S. Saddichha, N. Manjunatha,
S. Ameen, S. Akhtar
Acta Psychiatrica Scandinavica 2008;
117 (5), 342–347
3! - Incidence and diagnostic stability of ICD-10 acute and transient psychotic
disorders
Augusto Castagnini, Aksel
Bertelsen and
German E. Berrios
Comprehensive Psychiatry. Volume 49, Issue 3, May-June 2008, Pages 255-261
3! - Clinical profile of “schizo-obsessive”
disorder: a comparative study
Ravi Philip Rajkumar, Y.C. Janardhan
Reddyand Thennarasu Kandavel
Comprehensive Psychiatry. Volume 49, Issue 3, May-June 2008, Pages 262-268
3 - A
12-month, open-label, comparative study of quetiapine
and risperidone in the acute and long-term treatment
of schizophrenia
Perez, Victor; Canas,
Fernando; Tafalla, Monica; the TESIS Study Group
International
Clinical Psychopharmacology. 23(3):138-149, May 2008
3 -
Effects of antipsychotic medications on sleep in schizophrenia
Krystal, Andrew D; Goforth,
Harold W; Roth, Thomas
International Clinical
Psychopharmacology. 23(3):150-160,
May 2008
3! -
Patients' and Psychiatrists' Perceptions of Clinical Decisions During Schizophrenia Treatment
Hamann, Johannes; Mendel, Rosmarie
T; Fink, Barbara; Pfeiffer, Herbert; Cohen, Rudolf; Kissling,
Werner
Journal of Nervous & Mental
Disease. 196(4):329-332, April
2008
3 - Paliperidone for Treatment
of Schizophrenia
Abraham M. Nussbaum and T. Scott
Stroup
Schizophrenia
Bulletin 2008 34(3):419-422
3 - Oculomotor and
Neuropsychological Effects of Antipsychotic Treatment for Schizophrenia
S. Kristian
Hill, James L. Reilly, Margret S. H. Harris, Tin Khine
and John A. Sweeney
Schizophrenia
Bulletin 2008 34(3):494-506
3 - Cognition in Young Schizophrenia Outpatients:
Comparison of First-Episode With Multiepisode
Patients
Yoram Braw, Yuval Bloch, Shlomo Mendelovich, Gideon Ratzoni, Gilad Gal, Hagai Harari, Asaf
Tripto and Yechiel Levkovitz
Schizophrenia
Bulletin 2008 34(3):544-554
3! - Childhood Trauma and Psychotic Disorders: a
Systematic, Critical Review of the Evidence
Sarah Bendall,
Henry J. Jackson, Carol A. Hulbert and Patrick D. McGorry
Schizophrenia
Bulletin 2008 34(3):568-579
3! - Childhood Sexual Abuse, Early Cannabis Use, and
Psychosis: Testing an Interaction Model Based on the National Comorbidity Survey
James E. Houston, Jamie Murphy,
Gary Adamson, Maurice Stringer and Mark Shevlin
Schizophrenia
Bulletin 2008 34(3):580-585
3 - Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic
Approach to the Treatment of Schizophrenia
C. J. Schmidt, D. S. Chapin,
J. Cianfrogna, M. L. Corman,
M. Hajos, J. F. Harms, W.
E. Hoffman, L. A. Lebel, S. A. McCarthy, F. R. Nelson,
C. Proulx-LaFrance, M. J. Majchrzak, A. D. Ramirez, K.
Schmidt, P. A. Seymour, J. A. Siuciak, F. D. Tingley, III, R. D. Williams, P. R. Verhoest,
and F. S. Menniti
3< - Predicted Risk of Diabetes and Coronary Heart Disease
in Patients With Schizophrenia: Aripiprazole
Versus Standard of Care
Lawrence Blonde, Hong J. Kan, Elane M. Gutterman, Gilbert J. L'Italien, Myoung S. Kim, Linda Hanssens, and Robert D. McQuade
J Clin Psychiatry April 22, 2008: e1-e8
3 - Atypical antipsychotics in first-episode psychosis: A
review
J.-Y. Rotgé,
B. Aouizerate, J. Tignol
L’Encéphale. Vol 34 - N° 2 - Avril 2008 : 194 - 204
GRATIS 3 - Cognitive improvements
with antipsychotics: real or practice effect?
Terry Goldberg
Evidence-Based Mental Health 2008;11:42
GRATIS 3! - Metabolic syndrome common
in people with psychotic disorders, particularly in users of high potency
antipsychotics
Jaana Suivisaari
Evidence-Based Mental Health 2008;11:62
GRATIS 3! - Effectiveness of second generation
antipsychotics: A systematic review of randomized trials.
Erik
Johnsen and Hugo A
Jorgensen
4 - Antipsychotic-induced
tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions
P R Bakker, P
N van Harten and J van Os
Molecular Psychiatry
(2008) 13, 544–556
3! - Dopamine
Depletion of the Prefrontal Cortex Induces Dendritic Spine Loss: Reversal by
Atypical Antipsychotic Drug Treatment
Hui-Dong Wang and Ariel Y Deutch
Neuropsychopharmacology
(2008) 33, 1276–1286
3! - Acute Quetiapine Overdose
in Adults: A 5-Year Retrospective Case Series
Adeline Ngo, Michael Ciranni and Kent R.
Olson
Annals of Emergency Medicine. Article in Press, April 2008
5 - An 8-Week, Double-Blind, Randomized, Placebo-Controlled
Study of Olanzapine Long-Acting Injection in Acutely
Ill Patients With Schizophrenia
John Lauriello,
Tim Lambert, Scott Andersen, Daniel Lin, Cindy C. Taylor, and David McDonnell
J Clin Psychiatry April 29, 2008: e1-e10
2! - Life-Threatening Clozapine-Induced
Gastrointestinal Hypomotility: An Analysis of 102
Cases
Susanna E. Palmer, Rachael M. McLean, Peter
M. Ellis, and Mira Harrison-Woolrych
J Clin Psychiatry April 29, 2008: e1-e10
5! - Issues that
May Determine the Outcome of Antipsychotic Trials: Industry Sponsorship and Extrapyramidal Side Effect
John M Davis,
Nancy Chen and Ira D Glick
Neuropsychopharmacology (2008) 33, 971–975
4! - Predicting response to atypical antipsychotics based
on early response in the treatment of schizophrenia
Bruce J. Kinon, Lei Chen, Haya
Ascher-Svanum, Virginia L.Stauffer, Sara Kollack-Walker, Jennifer L. Sniadecki and John M. Kane
Schizophrenia Research. Article in
Press, May
2008
GRATIS 3! -
The Muscarinic Hypothesis of Schizophrenia:
Implications for Pharmacological Treatment
Thomas J. Raedler
Psychiatric Times 2008; Vol. 25 No. 5
GRATIS 3 - The Vesicular Monoamine Transporter: Basic and
Psychiatric Aspects
Karley Y.
Little, MD and Anish V. Sharda
Psychiatric Times 2008; Vol. 25 No. 5
| Regresar a RESÚMENES ABRIL 2008 |
